Browsing: Pharmaceutical Industry
AI lab Anthropic is making a major push into healthcare with the launch of Claude for Healthcare and an expansion…
Mark Cuban has an idea for how to stop the runaway train that is the $38 trillion national debt, and…
GLP-1s are the hottest drugs on the market. While doctors have prescribed these drugs to treat type-2 diabetes for decades,…
AI chip maker Nvidia’s fresh partnerships with Eli Lilly and Johnson & Johnson point to a broader trend in the…
Effective change management is the linchpin of enterprise-wide AI implementation, yet it’s often underestimated. I learned this first-hand in my…
When Ozempic and Wegovy launched, their bombshell success was only going to be exclusive to their maker—Novo Nordisk—for a matter…
Pfizer and AstraZeneca’s recent drug-pricing deals with the Trump Administration mark a sharp shift in how Washington is approaching the…
Billionaire venture capitalist Mark Cuban has not shied away from blasting President Donald Trump’s policy decisions, but he said Trump’s…
When President Donald Trump made his “Liberation Day” speech on April 2, announcing sweeping tariffs across a range of sectors,…
President Trump’s overnight decision to impose a 100% tariff on imported pharmaceuticals starting October 1 is already whacking the stock…